DELFI-L101: DNA Evaluation of Fragments for Early Interception – Lung Cancer Training Study


The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.

More information

Contact us

To learn more about clinical trials at ProHealth Care, email or call 262-928-3447.

Quick Access Links